Skip to content

Robert Wessman-led Aztiq completes $500 million transaction in an alliance with Innobic to create an international pharma powerhouse

By asianet

– The Consortium jointly, through Aztiq II HoldCo, has completed the acquisition of a 100% stake in Alvogen Emerging Markets Holdings Limited, thereby becoming the leading shareholders in Lotus Pharmaceuticals and Adalvo – Robert Wessman, Chairman and CEO of Alvogen and Founder of Aztiq Pharma Partners, will continue as Chairman of the board of Lotus … Continued

Series A financing round lays foundation for international growth of digital cancer therapeutics Mika

By asianet

New investors with a successful track record in digital oncology support German Digital Therapeutics (DTx) company Fosanis to broaden patient access of Mika – an app-based DTx platform empowering people affected by cancer. Berlin-based digital health company Fosanis, the developer of Mika, Germany’s first prescription DTx for all oncological indications, closed a series A funding … Continued

SICPA AND THE BATAILLON DE MARINS-POMPIERS DE MARSEILLE ARE TESTING AN INNOVATIVE SOLUTION FOR DETECTING PATHOGENS IN AIRCRAFT WASTEWATER

By asianet

The Swiss company SICPA, a world leader in identification, traceability and authentication technologies, and the bataillon de marins-pompiers de Marseille (BMPM – Marseille marine fire brigade), a French innovative biodefense unit, have developed a state-of-the-art technological solution, based on the analysis of aircraft wastewater to help authorities manage the risk of importing pathogens into their … Continued

World Lupus Federation Global Survey of People Living with Lupus finds 87% Report at Least One Major Organ Affected by the Disease

By asianet

— Survey Findings Released in Advance of World Lupus Day on May 10 In a recent international survey, the World Lupus Federation( https://c212.net/c/link/?t=0&l=en&o=3518634-1&h=1675888169&u=https%3A%2F%2Fworldlupusfederation.org%2F&a=World+Lupus+Federation ) found that 87% of the survey respondents living with lupus reported that the disease has impacted one or more major organs or organ systems. Over 6,700 people with lupus participated in … Continued

Insilico Medicine expands synthetic lethality portfolio with the nomination of a preclinical candidate targeting MAT2A for the treatment of MTAP-deleted cancers

By asianet

Insilico Medicine (“Insilico”), a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, today announced that the company has nominated a preclinical candidate (PCC) targeting methionine adenosyltransferase 2A (MAT2A) from AI-designed molecules for the treatment of methylthioadenosine phosphorylase (MTAP)-deleted cancers. The MAT2A program is part of Insilico’s growing portfolio of synthetic lethality assets in development. MTAP … Continued

HOYA Vision Care Releases Results of First of its Kind Six-Year MiYOSMART Spectacle Lens Follow-up Clinical Study

By asianet

— Strong evidence shows continued long-term lens effectiveness in slowing myopia progression in children HOYA Vision Care ( https://c212.net/c/link/?t=0&l=en&o=3525428-1&h=2929097389&u=https%3A%2F%2Fwww.hoyavision.com%2F&a=HOYA+Vision+Care ), a leader in optical technology innovation, shared the results of a six-year follow-up clinical study ( https://c212.net/c/link/?t=0&l=en&o=3525428-1&h=3417434965&u=https%3A%2F%2Fwww.hoyavision.com%2Fabstract-6-years-result&a=six-year+follow-up+clinical+study ) on its award winning MiYOSMART spectacle lens with Defocus Incorporated Multiple Segments (D.I.M.S.) Technology at the Association … Continued

European Stroke Organisation Conference 2022: New study links gut microbiota strains with more severe strokes and poorer post-stroke recovery

By asianet

A new study has identified strains of gut microbiota that are associated with more severe strokes and worse post-stroke recovery, revealing that the gut microbiome could be an important factor in stroke risk and outcomes. The study, presented today at the European Stroke Organisation Conference (ESOC 2022) pinpointed specific groups of bacteria associated with poorer … Continued

Sun Nuclear Introduces SunSCAN(TM) 3D, Next-Generation Cylindrical Water Scanning System

By asianet

– System to Debut at ESTRO Annual Congress & Upcoming Online Release Event Sun Nuclear Corporation (Sun Nuclear) ( https://c212.net/c/link/?t=0&l=en&o=3522597-1&h=3545425273&u=https%3A%2F%2Fwww.sunnuclear.com%2F&a=Sun+Nuclear+Corporation ), a wholly-owned subsidiary of Mirion Technologies, Inc. (NYSE: MIR) (“Mirion”), today announced the release of the SunSCAN(TM) 3D cylindrical water scanning system ( https://c212.net/c/link/?t=0&l=en&o=3522597-1&h=2126149412&u=https%3A%2F%2Fwww.sunnuclear.com%2Fproducts%2Fsunscan3d&a=SunSCAN%E2%84%A2+3D+cylindrical+water+scanning+system ) for linear accelerator (linac) commissioning, beam scanning and annual … Continued

Mediso acquires nuclear medicine supplier Bartec Technologies

By asianet

Mediso Ltd today announced the acquisition of Bartec Technologies Ltd, UK based company specialised in the supply, installation and support of Nuclear Medicine and Molecular Imaging equipment and accessories. The acquisition strengthens Mediso’s market position in the UK and Ireland. Financial details of the acquisition were not disclosed. Mediso Medical Imaging Systems with headquarters in … Continued

Ascensia Diabetes Care Presents News Research Showing that People Uing the Contour(R) Blood Glucose Monitoring System and App Experience Few Out-Of-Target Blood Glucose Levels

By asianet

Ascensia Diabetes Care, a global diabetes care company, maker of CONTOUR(R) blood glucose monitoring (BGM) system portfolio and distributor of the Eversense(R) continuous glucose monitoring (CGM) system, announces a new study demonstrating that people who use the connected CONTOUR(R) BGM systems (BGMS) and CONTOUR(R)DIABETES App (CDA) for at least six months can see a reduced … Continued